Cellular Logistics
Madison, US · Founded 2016 · Wisconsin corporation
Cellular Logistics develops CFX, a therapeutic biomaterial made with induced pluripotent stem cell technology that can be locally administered to prevent the pathological changes leading to heart failure after an acute injury such as myocardial infarction. Combined with therapeutic stem cells, it aims to remuscularize scarred myocardium to restore heart function in chronic heart failure.
BiotechMedical DevicesNew Materials
Founders & leadership
ES
Eric SchmuckExecutive Officer
AR
Amish RavalExecutive Officer, Director
AV
Alex VodenlichExecutive Officer, Director
PR
Paul ResnickDirector
Competitors · 1
by search overlapCompanies competing with Cellular Logistics for the same Google search keywords, organic and paid, via search-intersection analysis.
Reported raises · per SEC filings
Form D private placements▶$50KraisedJul 2026 · 1 investors · BiotechnologyRule 506(b)
▶$50KraisedJul 2026 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Amish RavalExecutive Officer, Director
- Eric SchmuckExecutive Officer
- Alex VodenlichExecutive Officer, Director
- Offering amount
- $100K
- Amount sold
- $50K
- Minimum investment
- $25K
- Proceeds to insiders
- $10K
- First sale
- Jun 2026
- Incorporated
- Corporation, Wisconsin
- Federal exemptions
- 06b
▶$50KraisedApr 2025 · 2 investors · BiotechnologyRule 506(b)
▶$50KraisedApr 2025 · 2 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Alex VodenlichExecutive Officer, Director
- Eric SchmuckExecutive Officer
- Amish RavalExecutive Officer, Director
- Offering amount
- $350K
- Amount sold
- $50K
- Minimum investment
- $25K
- Proceeds to insiders
- $50K
- First sale
- Mar 2025
- Incorporated
- Corporation, Wisconsin
- Federal exemptions
- 06b
▶$50KraisedMar 2023 · 2 investors · BiotechnologyRule 506(b)
▶$50KraisedMar 2023 · 2 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Eric SchmuckExecutive Officer
- Alex VodenlichExecutive Officer, Director
- Paul ResnickDirector
- Amish RavalDirector
- Offering amount
- $350K
- Amount sold
- $50K
- Minimum investment
- $25K
- Proceeds to insiders
- $50K
- First sale
- Mar 2023
- Incorporated
- Corporation, Wisconsin
- Federal exemptions
- 06b
▶$37.5KraisedMay 2021 · 1 investors · BiotechnologyRule 506(b)
▶$37.5KraisedMay 2021 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Amish RavalDirector
- Eric SchmuckExecutive Officer
- Alex VodenlichExecutive Officer, Director
- Paul ResnickDirector
- Offering amount
- $37.5K
- Amount sold
- $37.5K
- Minimum investment
- $37.5K
- First sale
- May 2021
- Incorporated
- Corporation, Wisconsin, 2016
- Federal exemptions
- 06b
▶$75KraisedJun 2019 · 3 investors · BiotechnologyRule 506(b)
▶$75KraisedJun 2019 · 3 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Zach BowerExecutive Officer
- Amish RavalExecutive Officer, Director, Promoter
- Eric SchmuckExecutive Officer, Promoter
- Alex VodenlichExecutive Officer, Director
- Paul ResnickDirector
- Offering amount
- $500K
- Amount sold
- $75K
- Minimum investment
- $25K
- Proceeds to insiders
- $50K
- First sale
- May 2019
- Incorporated
- Corporation, Wisconsin, 2016
- Federal exemptions
- 06b
▶$617.7KraisedNov 2018 · 13 investors · BiotechnologyRule 506(b)
▶$617.7KraisedNov 2018 · 13 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Adam BockPromoter
- Alex VodenlichExecutive Officer
- Eric SchmuckExecutive Officer, Promoter
- Amish RavalExecutive Officer, Director, Promoter
- Peiman HemattiExecutive Officer, Promoter
- Offering amount
- $617.7K
- Amount sold
- $617.7K
- Minimum investment
- $25K
- Proceeds to insiders
- $65K
- First sale
- Nov 2018
- Incorporated
- Corporation, Wisconsin, 2016
- Federal exemptions
- 06b
▶$5KraisedJun 2017 · 1 investors · BiotechnologyRule 506(b)
▶$5KraisedJun 2017 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Adam BockExecutive Officer, Director, Promoter
- Amish RavalExecutive Officer, Director, Promoter
- Rakesh SoniExecutive Officer, Director
- Eric SchmuckExecutive Officer, Promoter
- Peiman HemattiExecutive Officer, Promoter
- Offering amount
- $5K
- Amount sold
- $5K
- First sale
- Jun 2017
- Incorporated
- Corporation, Wisconsin, 2016
- Federal exemptions
- 06b
▶$185KraisedNov 2016 · 6 investors · BiotechnologyRule 506(b)
▶$185KraisedNov 2016 · 6 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Amish RavalExecutive Officer, Director, Promoter
- Peiman HemattiExecutive Officer, Promoter
- Eric SchmuckExecutive Officer, Promoter
- Rakesh SoniExecutive Officer
- Adam BockExecutive Officer, Director, Promoter
- Offering amount
- $500K
- Amount sold
- $185K
- Proceeds to insiders
- $65K
- First sale
- Nov 2016
- Incorporated
- Corporation, Wisconsin, 2016
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Non-dilutive funding · 2 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2022 | $337.1K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2021 | $320.7K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.